LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.43
+5.03%Oct 16, 2026, 20:34 UTC
NASDAQ, INC. notified Lucid Diagnostics Inc. that it was not in compliance with NASDAQ, INC. Listing Rule 5550(a)(2) because of its share price, giving the company until April 12, 2027, to regain compliance.
Aug 13, 2026, 14:11 UTC
Lucid Diagnostics Inc. reported a Q2 2026 loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.04 loss and improving from a $0.10 loss a year earlier.
Source: